BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7592628)

  • 1. Characterization of two activated mutants of human pp60c-src that escape c-Src kinase regulation by distinct mechanisms.
    Bjorge JD; Bellagamba C; Cheng HC; Tanaka A; Wang JH; Fujita DJ
    J Biol Chem; 1995 Oct; 270(41):24222-8. PubMed ID: 7592628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
    Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
    Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective binding of activated pp60c-src by an immobilized synthetic phosphopeptide modeled on the carboxyl terminus of pp60c-src.
    Roussel RR; Brodeur SR; Shalloway D; Laudano AP
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10696-700. PubMed ID: 1720546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of the SH3 domain of Src interferes with regulation by the phosphorylated carboxyl-terminal tyrosine.
    Okada M; Howell BW; Broome MA; Cooper JA
    J Biol Chem; 1993 Aug; 268(24):18070-5. PubMed ID: 7688738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid and efficient purification of Src homology 2 domain-containing proteins: Fyn, Csk and phosphatidylinositol 3-kinase p85.
    Koegl M; Kypta RM; Bergman M; Alitalo K; Courtneidge SA
    Biochem J; 1994 Sep; 302 ( Pt 3)(Pt 3):737-44. PubMed ID: 7524477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nonreceptor protein-tyrosine kinase CSK complexes directly with the GTPase-activating protein-associated p62 protein in cells expressing v-Src or activated c-Src.
    Neet K; Hunter T
    Mol Cell Biol; 1995 Sep; 15(9):4908-20. PubMed ID: 7544435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common in vitro substrate specificity and differential Src homology 2 domain accessibility displayed by two members of the Src family of protein-tyrosine kinases, c-Src and Hck.
    Sicilia RJ; Hibbs ML; Bello PA; Bjorge JD; Fujita DJ; Stanley IJ; Dunn AR; Cheng HC
    J Biol Chem; 1998 Jul; 273(27):16756-63. PubMed ID: 9642231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the binding of the Src homology 2 domain of Csk to tyrosine-phosphorylated proteins in the suppression and mitotic activation of c-Src.
    Sabe H; Hata A; Okada M; Nakagawa H; Hanafusa H
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3984-8. PubMed ID: 7513429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of a physical and functional interaction between Csk and Lck which involves the SH2 domain of Csk and is mediated by autophosphorylation of Lck on tyrosine 394.
    Bougeret C; Delaunay T; Romero F; Jullien P; Sabe H; Hanafusa H; Benarous R; Fischer S
    J Biol Chem; 1996 Mar; 271(13):7465-72. PubMed ID: 8631775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphopeptide occupancy and photoaffinity cross-linking of the v-Src SH2 domain attenuates tyrosine kinase activity.
    Garcia P; Shoelson SE; Drew JS; Miller WT
    J Biol Chem; 1994 Dec; 269(48):30574-9. PubMed ID: 7527032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides.
    Bibbins KB; Boeuf H; Varmus HE
    Mol Cell Biol; 1993 Dec; 13(12):7278-87. PubMed ID: 7504171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing the communication between the regulatory and catalytic domains of a protein tyrosine kinase, Csk.
    Lin X; Ayrapetov MK; Lee S; Parang K; Sun G
    Biochemistry; 2005 Feb; 44(5):1561-7. PubMed ID: 15683240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Csk inhibition of c-Src activity requires both the SH2 and SH3 domains of Src.
    Superti-Furga G; Fumagalli S; Koegl M; Courtneidge SA; Draetta G
    EMBO J; 1993 Jul; 12(7):2625-34. PubMed ID: 7687537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyoma virus middle T antigen-pp60c-src complex associates with purified phosphatidylinositol 3-kinase in vitro.
    Auger KR; Carpenter CL; Shoelson SE; Piwnica-Worms H; Cantley LC
    J Biol Chem; 1992 Mar; 267(8):5408-15. PubMed ID: 1372000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527.
    Cobb BS; Parsons JT
    Oncogene; 1993 Nov; 8(11):2897-903. PubMed ID: 7692368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional diversity of Csk, Chk, and Src SH2 domains due to a single residue variation.
    Ayrapetov MK; Nam NH; Ye G; Kumar A; Parang K; Sun G
    J Biol Chem; 2005 Jul; 280(27):25780-7. PubMed ID: 15890649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyomavirus middle-T antigen associates with the kinase domain of Src-related tyrosine kinases.
    Dunant NM; Senften M; Ballmer-Hofer K
    J Virol; 1996 Mar; 70(3):1323-30. PubMed ID: 8627648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of SH2 domain/phosphoprotein association by a nonhydrolyzable phosphonopeptide.
    Domchek SM; Auger KR; Chatterjee S; Burke TR; Shoelson SE
    Biochemistry; 1992 Oct; 31(41):9865-70. PubMed ID: 1382595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophosphorylation induces autoactivation and a decrease in the Src homology 2 domain accessibility of the Lyn protein kinase.
    Sotirellis N; Johnson TM; Hibbs ML; Stanley IJ; Stanley E; Dunn AR; Cheng HC
    J Biol Chem; 1995 Dec; 270(50):29773-80. PubMed ID: 8530369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Csk suppression of Src involves movement of Csk to sites of Src activity.
    Howell BW; Cooper JA
    Mol Cell Biol; 1994 Aug; 14(8):5402-11. PubMed ID: 7518562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.